Effect of GnRH analogues and octreotide treatment on apoptosis and the cell proliferation of endometrium adenocarcinoma cell lines.
暂无分享,去创建一个
[1] K. Ushijima. [Hormonal treatment of endometrial cancer]. , 2012, Nihon rinsho. Japanese journal of clinical medicine.
[2] P. Leung,et al. Reproductive Biology and Endocrinology Gonadotropin-releasing Hormone (gnrh)-i and Gnrh-ii Induce Cell Growth Inhibition in Human Endometrial Cancer Cells: Involvement of Integrin Beta3 and Focal Adhesion Kinase Background , 2022 .
[3] P. Leung,et al. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha. , 2009, Cancer research.
[4] N. Park,et al. Gonadotropin-releasing Hormone Receptor Expression in Endometrial Cancer , 2009, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[5] J. Schmitt,et al. Frequent expression of immunoreactive somatostatin receptors in cervical and endometrial cancer. , 2003, Gynecologic oncology.
[6] T. Bäckström,et al. Apoptosis, proliferation, and hormone receptors in endometrial carcinoma: results depending on methods of analysis. , 2003, International journal of oncology.
[7] チェン チェン,et al. Gonadotropin-releasing hormone receptor antagonist , 2002 .
[8] G. Emons,et al. Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation. , 2002, The Journal of clinical endocrinology and metabolism.
[9] E. Latta,et al. PTEN mutations and evolving concepts in endometrial neoplasia , 2002, Current opinion in obstetrics & gynecology.
[10] G. Emons,et al. Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers: frequency, autoregulation, and correlation with direct antiproliferative activity of luteinizing hormone-releasing hormone analogues. , 2002, American journal of obstetrics and gynecology.
[11] M. Paglierani,et al. Inhibitory effect of luteinising hormone-releasing hormone analogues on human endometrial cancer in vitro. , 2000, Cancer letters.
[12] Y. Taketani,et al. Inhibition of human endometrial cancer cell growth in vitro and in vivo by somatostatin analog RC-160. , 1999, American journal of obstetrics and gynecology.
[13] M. Arends. Apoptosis in the endometrium , 1999, Histopathology.
[14] V. Müller,et al. Effects of LHRH-analogues on mitogenic signal transduction in cancer cells 1 1 Proceedings of the 13th International Symposium of the Journal of Steroid Biochemistry & Molecular Biology “Recent Advances in Steroid Biochemistry & Molecular Biology” Monaco 25–28 May 1997. , 1998, The Journal of Steroid Biochemistry and Molecular Biology.
[15] A. Schally,et al. Mechanisms of Antineoplastic Action of Somatostatin Analogs , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[16] T. Tamaya,et al. Evidence for tight coupling of gonadotropin-releasing hormone receptor to stimulated Fas ligand expression in reproductive tract tumors: possible mechanism for hormonal control of apoptotic cell death. , 1998, The Journal of clinical endocrinology and metabolism.
[17] T. Furui,et al. Gonadotropin‐releasing hormone receptor in gynecologic tumors. Frequent expression in adenocarcinoma histologic types , 1994, Cancer.
[18] T. Furui,et al. Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium. , 1994, Gynecologic oncology.
[19] A. Schally,et al. Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: role of apoptosis. , 1994, American journal of obstetrics and gynecology.
[20] A. Schally,et al. High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines. , 1993, The Journal of clinical endocrinology and metabolism.
[21] G. Emons,et al. Intracellular actions of gonadotropic and peptide hormones and the therapeutic value of GnRH‐agonists in ovarian cancer , 1992, Acta obstetricia et gynecologica Scandinavica. Supplement.
[22] M. Slevin,et al. A new treatment for endometrial cancer with gonadotrophin releasing‐hormone analogue , 1991, British journal of obstetrics and gynaecology.
[23] R. Sylvester,et al. Zoladex and Flutamide Versus Orchiectomy in the Treatment of Advanced Prostatic Cancer , 1990, Cancer.
[24] R. Santen,et al. Treatment of breast cancer with gonadotropin-releasing hormone. , 1986, Endocrine reviews.